Search results for "EPA"

showing 10 items of 8995 documents

Burkholderia cepacia septicemia in a patient with acute myeloid leukemia in postchemotherapy bone marrow aplasia

2013

The patients with hematologic malignancies are predisposed to develop infections with unusual bacteria, like Burkholderia cepacia, which is frequently resistant to many antibiotics and antiseptics. We present the case of a female patient with acute myeloid leukemia type 2 on the background of myelodysplastic syndrome, from whom Burkholderia cepacia was isolated in blood culture, after the 2(nd) cycle of induction. She was sensitive to ceftazidime, but its eradication was not easy. Five other patients were contaminated with this bacteria, but all of them had favourable evolution. The case is discussed in the context of those similar in literature.

Acute myeloid leukemiabiologymedicine.diagnostic_testbusiness.industrymedicine.drug_classAntibioticsMyeloid leukemiaCeftazidimeContext (language use)Case ReportGeneral MedicineBone Marrow AplasiaBurkholderia cepaciabiology.organism_classificationCeftazidimeMicrobiologyCotrimoxazoleBurkholderiaImmunologyMedicinebacteriaBlood culturebusinessBacteriamedicine.drugPakistan Journal of Medical Sciences
researchProduct

Insufficienza renale acuta in paziente con carcinoma epatocellulare sottoposto a chemioembolizzazione transarteriosa

2007

Transarterial chemoembolization (TACE) is included among the wide therapeutic tools for the treatment of hepatocellular carcinoma (HCC), tumour with high frequency and malignancy. The approach is invasive and, beyond the discomfort for the patient, it is charged by a number of side effects and complications. In this study we report the case of renal acute failure of hypovolemic origin, as a consequence of a TACE in a patient suffering from HCC, occurred after one week of intervention. The different possible mechanisms involved in the pathogenesis of this complication are discussed.

Acute renal failureHepatocellular carcinomaMedicine (all)Trans-arterial chemioembolization
researchProduct

Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy

2019

AbstractBackground: Lifetime incidence of colorectal cancer (CRC) especially in carriers of MLH1 and MSH2 pathogenic germline variants in mismatch repair genes is high despite ongoing colonoscopy s...

AdenomaAdultMaleOncologycongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyHereditary non-polyposis colorectal cancerCOLONOSCOPYColorectal cancersurveillance colonoscopyeducationColonoscopycolorectal cancerMLH1Germline03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansRegistriesneoplasmsFinlandAgedNeoplasm StagingRetrospective Studiesmedicine.diagnostic_testbusiness.industryIncidenceIncidence (epidemiology)LYNCH SYNDROMEGastroenterologynutritional and metabolic diseasesMiddle Agedmedicine.diseaseColorectal Neoplasms Hereditary Nonpolyposisdigestive system diseasesLynch syndrome3. Good healthMSH2Population Surveillance030220 oncology & carcinogenesis3121 General medicine internal medicine and other clinical medicineFemale030211 gastroenterology & hepatologyDNA mismatch repairColorectal Neoplasmsbusiness
researchProduct

Endoscopic therapy of adenomas of the papilla of Vater. A retrospective analysis with long-term follow-up.

2001

Abstract Aims. To compare the efficacy and the complication rate between endoscopic snare resection of adenomas of Vater's papilla and endoscopic palliation. Methods. In a retrospective, non randomized manner, we compared long-term results of our endoscopic strategies in 36 patients with histologically confirmed adenoma of Vater's papilla submitted either to local endoscopic snare resection (n=18) or to simple endoscopic palliation (n=18), respectively. Results. Between 1985 and 1998 results were reviewed. Median age was 76.5 (range 42–89) years in the palliation, and 64.0(23–89) years in the endoscopic snare resection group. Median duration of follow-up was 33 (6–135) and 75.0 (27–123) mon…

AdenomaAdultMalemedicine.medical_specialtyAmpulla of VaterAdenomamedicine.medical_treatmentCommon Bile Duct NeoplasmsAdenocarcinomaProsthesisMcNemar's testmedicineHumansAgedRetrospective StudiesAged 80 and overHepatologybusiness.industryMortality rateIncidence (epidemiology)GastroenterologyRetrospective cohort studyEndoscopyMiddle Agedmedicine.diseaseSurvival Analysisdigestive system diseasesSurgeryMajor duodenal papillaCell Transformation NeoplasticTreatment OutcomeAdenocarcinomaFemalebusinessDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
researchProduct

Expression of glial filament protein (GFP) in nerve sheaths and non-neural cells re-examined using monoclonal antibodies, with special emphasis on th…

1986

We describe two novel monoclonal antibodies specific for glial filament protein (GFP), i.e., GF12.23 and GF12.24 (both IgG2a]. These cross-react over a broad range of species with epitopes located in the alpha-helical rod domain typical of all intermediate filament (IF) proteins. These monoclonal antibodies were used, in conjunction with other monoclonal GFP antibodies, rabbit antiserum to GFP, and various antibodies to other cytoskeletal proteins, to examine the occurrence of GFP in cells outside of the central nervous system of rodents, cows, and humans. We detected some scattered GFP-containing cells in the neural sheaths in some species but not in others, and we obtained different resul…

AdenomaCancer Researchmedicine.drug_classGuinea PigsAdenoma PleomorphicFluorescent Antibody TechniqueCross ReactionsMonoclonal antibodyEyeEpitopeEpitheliumSalivary GlandsGreen fluorescent proteinEpitopesSpecies SpecificityGlial Fibrillary Acidic ProteinmedicineAnimalsHumansVimentinIntermediate filamentMolecular BiologyMyelin SheathbiologyMyoepithelial cellAntibodies MonoclonalCell BiologyMolecular biologyRatsMicroscopy FluorescenceMonoclonalImmunologybiology.proteinHepatic stellate cellKeratinsCattleAntibodyDevelopmental BiologyDifferentiation; research in biological diversity
researchProduct

Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polyps

2018

Abstract Background Prediction of histology of small polyps facilitates colonoscopic treatment. The aims of this study were: 1) to develop a simplified polyp classification, 2) to evaluate its performance in predicting polyp histology, and 3) to evaluate the reproducibility of the classification by trainees using multiplatform endoscopic systems. Methods In phase 1, a new simplified endoscopic classification for polyps – Simplified Identification Method for Polyp Labeling during Endoscopy (SIMPLE) – was created, using the new I-SCAN OE system (Pentax, Tokyo, Japan), by eight international experts. In phase 2, the accuracy, level of confidence, and interobserver agreement to predict polyp hi…

AdenomaMODULEValidation studymedicine.medical_specialtyConsensusDelphi TechniqueI-SCANColonoscopyColonic PolypsCOMMUNITY PRACTICE03 medical and health sciencesNarrow Band Imaging0302 clinical medicineEXPERTSPredictive Value of TestsOptical diagnosisADENOMASmedicineHumansHISTOLOGYObserver VariationReproducibilitymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsColonoscopyCOLON POLYPSPredictive valueConfidence intervalEndoscopyTumor Burden030220 oncology & carcinogenesisPredictive value of testsAGREEMENTOPTICAL DIAGNOSIS030211 gastroenterology & hepatologyRadiologybusinessColorectal NeoplasmsEndoscopy
researchProduct

Colonoscopy and reduction of colorectal cancer risk by molecular tumor subtypes: a population-based case-control study

2020

AbstractObjectiveIn previous studies, the protective effect of colonoscopy was generally stronger for distal than for proximal colorectal cancer (CRC). This study aimed to investigate whether the association of colonoscopy and CRC risk varies according to major molecular pathological features and pathways of CRC.DesignPopulation-based case-control study from Germany, including 2132 patients with a first diagnosis of CRC and information on major molecular tumor markers, and 2486 control participants without CRC. Detailed participant characteristics were collected by standardized questionnaires and information on previous colonoscopy was derived from medical records. Polytomous logistic regre…

AdenomaMaleProto-Oncogene Proteins B-rafOncologymedicine.medical_specialtyColorectal cancerPopulationRectumColonoscopymedicine.disease_cause03 medical and health sciences0302 clinical medicineGermanyInternal medicineBiomarkers TumormedicineHumanseducationneoplasmsAgedAged 80 and overeducation.field_of_studyHepatologyCpG Island Methylator Phenotypemedicine.diagnostic_testbusiness.industryGastroenterologyCase-control studyCancerColonoscopyOdds ratioDNA MethylationMiddle Agedmedicine.diseaseConfidence intervaldigestive system diseasesmedicine.anatomical_structureCase-Control Studies030220 oncology & carcinogenesisMutationCpG IslandsFemaleMicrosatellite Instability030211 gastroenterology & hepatologyObservational studyKRASColorectal Neoplasmsbusiness
researchProduct

Rural–urban differences in the long-term risk of colorectal cancer after adenoma removal: A population-based study

2013

Abstract Background We investigated the impact of municipality of residence on colonoscopic surveillance and colorectal cancer risk after adenoma resection in a French well-defined administrative area. Methods This registry-based study included all patients residing in Cote d’Or (n = 5769) first diagnosed with colorectal adenomas between January 1, 1990, and December 31, 1999. Information about colonoscopic surveillance and colorectal cancer incidence was collected until December 31, 2003. Results A rural place of residence reduced the probability of colonoscopic surveillance in men [HR = 0.89 (95%CI: 0.79–0.99), p = 0.041] and in patients without family history of colorectal cancer [HR = 0…

AdenomaMaleRiskRural Populationmedicine.medical_specialtyUrban PopulationAdenomaColorectal cancerPopulationColorectal adenomaCohort StudiesInternal medicinemedicineHumansFamily historyeducationAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overeducation.field_of_studyGeographyHepatologybusiness.industryIncidenceIncidence (epidemiology)General surgeryCarcinomaConfoundingGastroenterologyColonoscopyMiddle Agedmedicine.diseaseStandardized mortality ratioFemaleFranceColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Faecal immunochemical tests: A valuable tool for colorectal cancer screening

2012

Colorectal cancer is a major health problem in industrialized ountries and fulfils the conditions required to justifymass screenng of the general population. Population-based controlled studies erformed in Europe have shown that guaiac faecal occult blood esting (G-FOBT) followed by colonoscopy to detect the cause of leeding can reduce colorectal cancer mortality [1]. Nearly all pubished studies evaluated the Hemoccult II (Beckman Coulter Inc., ea, USA) faecal occult blood test. Screening for colorectal caner using FOBT has, therefore, been included in the European Code gainst Cancer and has been endorsed by the European Commision [2]. Despite its high specificity, Hemoccult has been critic…

AdenomaMalemedicine.medical_specialtyColorectal cancerPopulationColonoscopyImmunologic TestsControlled studiesInternal medicinemedicineHumanseducationBlood testingEarly Detection of Cancereducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyCancerFaecal occult bloodmedicine.diseaseColorectal cancer screeningOccult BloodFemaleColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations – a randomized trial in Latvia

2016

OBJECTIVE We have compared the performance of two faecal immunochemical tests (FIT) in an average-risk population. MATERIALS AND METHODS Altogether, 10 000 individuals aged 50-74 were selected randomly from the population of Latvia in 2011 and assigned randomly either to OC-Sensor or to FOB Gold single-time testing. Positivity of the test, frequency of colonic lesions, number needed to screen (NNscreen) and scope for the detection of an advanced neoplasm (cancer and advanced adenoma) were compared between the tests using the same cutoff concentrations in µg/g faeces. Confidence intervals (CIs) at 95% were calculated. RESULTS Positivity with the cutoff set at 10 µg/g faeces was 12.8% (95% CI…

AdenomaMalemedicine.medical_specialtyPopulationColonoscopyGastroenterologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPredictive Value of TestslawInternal medicineHumansMass ScreeningMedicineCutoffeducationFecesAgededucation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsColonoscopyMiddle AgedImmunohistochemistryLatviaNumber needed to screenConfidence intervalOccult Blood030220 oncology & carcinogenesisPredictive value of testsFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessEuropean Journal of Gastroenterology & Hepatology
researchProduct